Demographics and Risk Profile of Elderly Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study

References

• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez JA, Sterne JAC, Thom HHZ, et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 2017;359:j5058. doi:10.1136/bmj.j5058
   PubMed Web of Science ®Google Scholar
• Gómez-Doblas JJ, Muñiz J, Martin JJ, et al. OFRECE study collaborators. Prevalence of atrial fibrillation in Spain. OFRECE study results. Rev Esp Cardiol. 2014;67(4):259–269. doi:10.1016/j.rec.2013.07.014
   PubMed Web of Science ®Google Scholar
• Azar RR, Ragy HI, Kozan O, et al. Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program. Int J Cardiol Heart Vasc. 2021;34:100763. doi:10.1016/j.ijcha.2021.100763
   PubMed Web of Science ®Google Scholar
• Healey JS, Oldgren J, Ezekowitz M, et al. RE-LY Atrial Fibrillation Registry and Cohort Study Investigators. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. Lancet. 2016;388(10050):1161–1169. doi:10.1016/S0140-6736(16)30968-0
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Otto CM. “Heartbeat: the worldwide burden of atrial fibrillation. Heart. 2018;104:1987–1988. doi:10.1136/heartjnl-2018-314443
   PubMed Web of Science ®Google Scholar
• Bassand JP, Virdone S, Goldhaber SZ, et al. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation. Circulation. 2019;139(6):787–798. doi:10.1161/CIRCULATIONAHA.118.035012
   PubMed Web of Science ®Google Scholar
• Hammoudeh AJ, Khader Y, Kadri N, et al. Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: the Jordan Atrial Fibrillation (JoFib) Study. Int J Vasc Med. 2021;2021:5515089. doi:10.1155/2021/5515089
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272. doi:10.1378/chest.09-1584
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093–1100. doi:10.1378/chest.10-0134
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104–132. doi:10.1016/j.jacc.2019.01.011
   PubMed Web of Science ®Google Scholar
• Zubaid M, Rashed WA, Alsheikh-Ali AA, et al. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators. Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East. Circ Cardiovasc Qual Outcomes. 2011;4(4):477–482. doi:10.1161/CIRCOUTCOMES.110.959700
   PubMed Web of Science ®Google Scholar
• Hiasa KI, Kaku H, Inoue H, et al. Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan - Insight From the ANAFIE (All Nippon AF In Elderly) Registry. Circ J. 2020;84(3):388–396. doi:10.1253/circj.CJ-19-0898
   PubMed Web of Science ®Google Scholar
• Xing L, Lin M, Du Z, et al. Epidemiology of atrial fibrillation in northeast China: a cross-sectional study, 2017-2019. Heart. 2020;106(8):590–595. doi:10.1136/heartjnl-2019-315397
   PubMed Web of Science ®Google Scholar
• Salam AM, AlBinali HA, Al-Mulla AW, Singh R, Al Suwaidi J. Secular trends, treatments, and outcomes of Middle Eastern Arab and South Asian patients hospitalized with atrial fibrillation: insights from a 20-year registry in Qatar (1991-2010). Angiology. 2013;64(7):498–504. doi:10.1177/0003319712460332
   PubMed Web of Science ®Google Scholar
• Lip GYH, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012;142(6):1489–1498. doi:10.1378/chest.11-2888
   PubMed Web of Science ®Google Scholar
• El Kadri M, Bazargani N, Farghaly M, et al. Profiling clinical characteristics and treatment patterns among non-valvular atrial fibrillation patients: a real-world analysis in Dubai, United Arab Emirates. Open Med J. 2019;6:33–41. doi:10.2174/1874220301906010033
   Google Scholar
• Watkins DA, Johnson CO, Colquhoun SM, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med. 2017;377(8):713–722. doi:10.1056/NEJMoa1603693
   PubMed Web of Science ®Google Scholar
• He VY, Condon JR, Ralph AP, et al. Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: a Data-Linkage and Survival Analysis Approach. Circulation. 2016;134(3):222–232. doi:10.1161/CIRCULATIONAHA.115.020966
   PubMed Web of Science ®Google Scholar
• Manji RA, Ekser B, Menkis AH, Cooper DK. Bioprosthetic heart valves of the future. Xenotransplantation. 2014;21(1):1–10. doi:10.1111/xen.12080
   PubMed Web of Science ®Google Scholar
• Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J. 2004;68:568–572. doi:10.1253/circj.68.568
   PubMed Web of Science ®Google Scholar
• Kerr CR, Humphries KH, Talajic M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2005;149:489–496. doi:10.1016/j.ahj.2004.09.053
   PubMed Web of Science ®Google Scholar